Morgan Stanley’s Chimerix, Inc. CMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-861,372
Closed -$7.33M 8356
2025
Q1
$7.33M Buy
861,372
+777,324
+925% +$4.29M ﹤0.01% 3603
2024
Q4
$292K Buy
84,048
+23,006
+38% +$32.5K ﹤0.01% 5642
2024
Q3
$56.8K Sell
61,042
-14,727
-19% -$13.1K ﹤0.01% 6183
2024
Q2
$66.4K Buy
75,769
+7,570
+11% +$7.18K ﹤0.01% 6094
2024
Q1
$72.3K Sell
68,199
-699,129
-91% -$728K ﹤0.01% 6101
2023
Q4
$739K Buy
767,328
+83,975
+12% +$81.3K ﹤0.01% 5448
2023
Q3
$656K Buy
683,353
+84,799
+14% +$92.3K ﹤0.01% 5036
2023
Q2
$724K Sell
598,554
-435,022
-42% -$551K ﹤0.01% 5022
2023
Q1
$1.3M Buy
1,033,576
+259,600
+34% +$424K ﹤0.01% 4713
2022
Q4
$1.44M Sell
773,976
-37,297
-5% -$73K ﹤0.01% 4662
2022
Q3
$1.57M Sell
811,273
-34,361
-4% -$77.1K ﹤0.01% 4599
2022
Q2
$1.76M Buy
845,634
+426,557
+102% +$1.37M ﹤0.01% 4632
2022
Q1
$1.92M Buy
419,077
+239,551
+133% +$1.34M ﹤0.01% 4548
2021
Q4
$1.16M Buy
179,526
+50,744
+39% +$304K ﹤0.01% 4964
2021
Q3
$797K Buy
128,782
+79,505
+161% +$547K ﹤0.01% 5201
2021
Q2
$394K Buy
49,277
+17,533
+55% +$146K ﹤0.01% 5675
2021
Q1
$306K Sell
31,744
-73,807
-70% -$677K ﹤0.01% 5413
2020
Q4
$510K Buy
105,551
+45,064
+75% +$163K ﹤0.01% 5069
2020
Q3
$151K Buy
60,487
+16,607
+38% +$49.1K ﹤0.01% 5245
2020
Q2
$136K Buy
43,880
+13,109
+43% +$33.9K ﹤0.01% 5251
2020
Q1
$45K Sell
30,771
-69,845
-69% -$122K ﹤0.01% 5503
2019
Q4
$204K Sell
100,616
-1,747,578
-95% -$3.22M ﹤0.01% 5404
2019
Q3
$4.34M Sell
1,848,194
-666,353
-26% -$1.92M ﹤0.01% 3009
2019
Q2
$10.9M Buy
2,514,547
+816,955
+48% +$2.51M ﹤0.01% 2067
2019
Q1
$3.56M Sell
1,697,592
-439,543
-21% -$1M ﹤0.01% 3037
2018
Q4
$5.49M Buy
2,137,135
+95,985
+5% +$321K ﹤0.01% 2794
2018
Q3
$7.94M Buy
2,041,150
+456,290
+29% +$1.94M ﹤0.01% 2662
2018
Q2
$7.54M Sell
1,584,860
-201,078
-11% -$961K ﹤0.01% 2693
2018
Q1
$9.29M Sell
1,785,938
-261,779
-13% -$1.33M ﹤0.01% 2413
2017
Q4
$9.48M Buy
2,047,717
+322,042
+19% +$1.53M ﹤0.01% 2453
2017
Q3
$9.06M Buy
1,725,675
+2,085
+0.1% +$10.3K ﹤0.01% 2379
2017
Q2
$9.39M Buy
1,723,590
+1,105,516
+179% +$5.82M ﹤0.01% 2234
2017
Q1
$3.94M Buy
618,074
+414,717
+204% +$2.35M ﹤0.01% 3115
2016
Q4
$936K Sell
203,357
-235,683
-54% -$1.11M ﹤0.01% 4513
2016
Q3
$2.43M Buy
439,040
+299,244
+214% +$1.37M ﹤0.01% 3326
2016
Q2
$550K Sell
139,796
-28,019
-17% -$138K ﹤0.01% 4375
2016
Q1
$857K Sell
167,815
-19,348
-10% -$126K ﹤0.01% 4069
2015
Q4
$1.67M Buy
187,163
+92,005
+97% +$3.31M ﹤0.01% 3656
2015
Q3
$3.63M Sell
95,158
-12,174
-11% -$601K ﹤0.01% 2933
2015
Q2
$4.96M Sell
107,332
-3,553
-3% -$142K ﹤0.01% 2805
2015
Q1
$4.18M Sell
110,885
-5,503
-5% -$218K ﹤0.01% 2918
2014
Q4
$4.69M Sell
116,388
-7,382
-6% -$250K ﹤0.01% 2783
2014
Q3
$3.42M Sell
123,770
-7,695
-6% -$187K ﹤0.01% 2983
2014
Q2
$2.88M Sell
131,465
-23,726
-15% -$471K ﹤0.01% 3187
2014
Q1
$3.54M Buy
155,191
+60,596
+64% +$1.22M ﹤0.01% 2914
2013
Q4
$1.43M Sell
94,595
-15,279
-14% -$244K ﹤0.01% 3651
2013
Q3
$2.42M Sell
109,874
-61,559
-36% -$1.27M ﹤0.01% 3076
2013
Q2
$4.16M Buy
+171,433
New +$3.58M ﹤0.01% 2507

Other funds holding CMRX

Morgan Stanley's CMRX Position: Q2 2025 in Review

Morgan Stanley sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 861,372 shares — an estimated $7.33M sold.

Morgan Stanley first reported a position in CMRX in Q2 2013 and held it in 48 quarters. The position peaked at $10.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.

  • Morgan Stanley reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 861,372 Chimerix, Inc. shares in Q2 2025, an estimated $7.33M.
  • Morgan Stanley first reported a position in Chimerix, Inc. in Q2 2013 and held it in 48 quarters.
  • Morgan Stanley's Chimerix, Inc. position peaked at $10.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.